These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 8354485

  • 1. Chromogranin A, secretogranin II and vasoactive intestinal peptide in phaeochromocytomas and ganglioneuromas.
    Schmid KW, Dockhorn-Dworniczak B, Fahrenkamp A, Kirchmair R, Tötsch M, Fischer-Colbrie R, Böcker W, Winkler H.
    Histopathology; 1993 Jun; 22(6):527-33. PubMed ID: 8354485
    [Abstract] [Full Text] [Related]

  • 2. Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas.
    Eder U, Fischer-Colbrie R, Kogner P, Leitner B, Bjellerup P, Winkler H.
    Neurosci Lett; 1998 Aug 28; 253(1):17-20. PubMed ID: 9754794
    [Abstract] [Full Text] [Related]

  • 3. Comparison of chromogranins A, B, and secretogranin II in human adrenal medulla and pheochromocytoma.
    Schober M, Fischer-Colbrie R, Schmid KW, Bussolati G, O'Connor DT, Winkler H.
    Lab Invest; 1987 Oct 28; 57(4):385-91. PubMed ID: 3669614
    [Abstract] [Full Text] [Related]

  • 4. The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla.
    Tischler AS, Dayal Y, Balogh K, Cohen RB, Connolly JL, Tallberg K.
    Hum Pathol; 1987 Sep 28; 18(9):909-17. PubMed ID: 3623551
    [Abstract] [Full Text] [Related]

  • 5. Expression of chromogranins A, B, and C (secretogranin II) in human adrenal medulla and in benign and malignant pheochromocytomas An immunohistochemical study with region-specific antibodies.
    Portela-Gomes GM, Stridsberg M, Grimelius L, Falkmer UG, Falkmer S.
    APMIS; 2004 Oct 28; 112(10):663-73. PubMed ID: 15601318
    [Abstract] [Full Text] [Related]

  • 6. Expression of neuropeptides and other neuroendocrine markers in human phaeochromocytomas.
    Moreno AM, Castilla-Guerra L, Martínez-Torres MC, Torres-Olivera F, Fernández E, Galera-Davidson H.
    Neuropeptides; 1999 Apr 28; 33(2):159-63. PubMed ID: 10657486
    [Abstract] [Full Text] [Related]

  • 7. Vasoactive intestinal peptide and its relationship to ganglion cell differentiation in neuroblastic tumors.
    Mendelsohn G, Eggleston JC, Olson JL, Said SI, Baylin SB.
    Lab Invest; 1979 Aug 28; 41(2):144-9. PubMed ID: 222958
    [Abstract] [Full Text] [Related]

  • 8. Adrenal pheochromocytoma-ganglioneuroma producing catecholamines and various neuropeptides.
    Salmi J, Pelto-Huikko M, Auvinen O, Karvonen AL, Saaristo J, Paronen I, Pöyhönen L, Seppänen S.
    Acta Med Scand; 1988 Aug 28; 224(4):403-8. PubMed ID: 3188992
    [Abstract] [Full Text] [Related]

  • 9. Silent mixed ganglioneuroma/pheochromocytoma which produces a vasoactive intestinal polypeptide.
    Nagashima F, Hayashi J, Araki Y, Sugihara T, Nomura M, Morichika Y, Inoue J, Shibata S, Akagi E.
    Intern Med; 1993 Jan 28; 32(1):63-6. PubMed ID: 8495050
    [Abstract] [Full Text] [Related]

  • 10. Bilateral pheochromocytoma-ganglioneuroma of the adrenal in type 1 neurofibromatosis.
    Chetty R, Duhig JD.
    Am J Surg Pathol; 1993 Aug 28; 17(8):837-41. PubMed ID: 8338194
    [Abstract] [Full Text] [Related]

  • 11. Percutaneous biopsy of adrenal and extra-adrenal retroperitoneal lesions: beware of catecholamine secreting tumours!
    Sood SK, Balasubramanian SP, Harrison BJ.
    Surgeon; 2007 Oct 28; 5(5):279-81. PubMed ID: 17958227
    [Abstract] [Full Text] [Related]

  • 12. The neuroendocrine and neural profiles of neuroblastomas, ganglioneuroblastomas, and ganglioneuromas.
    Molenaar WM, Baker DL, Pleasure D, Lee VM, Trojanowski JQ.
    Am J Pathol; 1990 Feb 28; 136(2):375-82. PubMed ID: 1689542
    [Abstract] [Full Text] [Related]

  • 13. Immunoreactivity to chromogranin and to vasoactive intestinal peptide in a canine phaeochromocytoma.
    Cuervo L, Balaguer L, Romano J, Idigoras I, Gonzalez L.
    J Comp Pathol; 1994 Oct 28; 111(3):327-31. PubMed ID: 7836575
    [Abstract] [Full Text] [Related]

  • 14. Chromogranin A and B and secretogranin II in bronchial and intestinal carcinoids.
    Weiler R, Feichtinger H, Schmid KW, Fischer-Colbrie R, Grimelius L, Cedermark B, Papotti M, Bussolati G, Winkler H.
    Virchows Arch A Pathol Anat Histopathol; 1987 Oct 28; 412(2):103-9. PubMed ID: 2447696
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Identification of the secretogranin II-derived peptide EM66 in pheochromocytomas as a potential marker for discriminating benign versus malignant tumors.
    Yon L, Guillemot J, Montero-Hadjadje M, Grumolato L, Leprince J, Lefebvre H, Contesse V, Plouin PF, Vaudry H, Anouar Y.
    J Clin Endocrinol Metab; 2003 Jun 28; 88(6):2579-85. PubMed ID: 12788858
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.